The purpose of this study was to identify the trigger mechanism activating the 5-lipoxygenase pathway during blood-brain cell contact and to estimate the con tribution of blood and brain cells to the cysteinyl leukotriene (L T) biosynthesis observed under these con ditions, Incubation of dissociated rat brain cells in Krebs Henseleit solution for up to 60 min did not stimulate any detectable cysteinyl-L T biosynthesis. Incubation of re calcified rat whole blood in vitro for up to 60 min led to release of only small amounts of cysteinyl-L T into the serum samples. However, coincubation of dissociated rat brain cells with physiologically recalcified autologous whole blood triggered a time-dependent release of large amounts of immunoreactive cysteinyl-L T into the serum samples. By reverse-phase HPLC, immunoreactive cys teinyl-L T was identified as a mixture of LTC4, LTD4, and L TE4• The extent of the 5-lipoxygenase stimulation depended on the amount of autologous blood coincubated
Summary: The purpose of this study was to identify the trigger mechanism activating the 5-lipoxygenase pathway during blood-brain cell contact and to estimate the con tribution of blood and brain cells to the cysteinyl leukotriene (L T) biosynthesis observed under these con ditions, Incubation of dissociated rat brain cells in Krebs Henseleit solution for up to 60 min did not stimulate any detectable cysteinyl-L T biosynthesis. Incubation of re calcified rat whole blood in vitro for up to 60 min led to release of only small amounts of cysteinyl-L T into the serum samples. However, coincubation of dissociated rat brain cells with physiologically recalcified autologous whole blood triggered a time-dependent release of large amounts of immunoreactive cysteinyl-L T into the serum samples. By reverse-phase HPLC, immunoreactive cys teinyl-L T was identified as a mixture of LTC4, LTD4, and L TE4• The extent of the 5-lipoxygenase stimulation depended on the amount of autologous blood coincubated Cysteinyl-Ieukotrienes (LTs) are generated via the 5-lipoxygenase pathway of arachidonic acid me tabolism. In central nervous tissue their biosynthe sis was first demonstrated in vitro in rat brain slices stimulated with the ionophore A23187 (Dembinska Kiec et aI., 1984; Lindgren et aI., 1984) . In addition, biosynthesis of cysteinyl-L T has been reported in central nervous tissue from various other species including gerbils (Moskowitz et aI., 1984; Kiwak et aI., 1985; Simmet et aI., 1987 Simmet et aI., , 1988b , guinea pigs with the dissociated brain cells. Activation of the 5-li poxygenase pathway also occurred with coincubation of dissociated rat brain cells with recalcified autologous plasma. Stimulation of cysteinyl-L T biosynthesis during blood-brain cell contact remained unaffected by aproti nin, but concentration-dependent inhibition by the struc turally and functionally unrelated thrombin inhibitors D Phe-Pro-Arg-CH 2 Cl and recombinant hirudin was seen. Finally, when dissociated rat brain cells were incubated in Krebs-Henseleit solution in the presence of human a-thrombin, a concentration-dependent release of cystei nyl-L T into the buffer samples was observed. These data demonstrate that, in rats, during blood-brain cell contact, stimulation of the 5-lipoxygenase pathway in brain cells proceeds via a-thrombin as effector molecule. Key Words: Cysteinyl-Ieukotrienes-Dissociated brain cells-Subarachnoid hemorrhage-a-Thrombin Hirudin-D-Phe-Pro-Arg-CH 2 CI. (Shimizu et aI., 1987) , and humans (Simmet et aI., 1988a) . It has been suggested that cysteinyl-LT might play a role in neuroendocrine mechanisms (Hulting et aI., 1985; Kiesel et aI., 1991) and might act as a messenger or modulator of central nervous activity (Palmer et aI., 1981; Schweitzer et aI., 1990) . On the other hand, several pathophysiologi cal conditions, such as epileptic seizures (Simmet et aI., 1988b; Tippler 1990, 1991) , isch emic insult (Kiwak et aI., 1985; Simmet et aI., 1987; Minamisawa et ai., 1988; Ohtsuki et ai., 1995) , con cussive injury (Kiwak et ai., 1985) , and subarach noid hemorrhage (SAH) (Kiwak et al., 1985; Yokota et ai., 1987; Paoletti et ai., 1988; Shimizu et ai., 1988; Watanabe et aI., 1988; Gaetani et ai., 1992) , have been shown to trigger cerebral cystei nyl-L formation in vivo. With this information as background, it has been suggested that cysteinyl L T, known to be a potent smooth muscle constric tors in peripheral tissues, might contribute to cere bral vasospasm during SAH (Kiwak et ai., 1985; Yokota et aI., 1987; Shimizu et aI., 1988; Watanabe et aI., 1988) . In addition, it has been reported that patients with SAH having vasospasms had signifi cantly higher CSF levels of cysteinyl-L T than did patients without symptomatic vasospasm (Paoletti et aI., 1988; Rodriguez y Baena et aI., 1987 . This finding further supports the notion that cystei nyl-LT might play a pathophysiological role during SAH. So far, however, very little is known about the stimuli involved in the activation of the cerebral 5-lipoxygenase pathway under these pathophysio logical conditions. We therefore sought to identify the stimulus triggering activation of cysteinyl-LT biosynthesis during blood-brain cell contact as it might occur during SAH. Moreover, we wanted to clarify whether cysteinyl-LT generated during blood-brain cell contact is primarily generated by cerebral tissues or by blood cells such as polymor phonuclear neutrophils. Similar to the experience of other authors (Gebicke-Haerter et aI., 1991) , in our hands astroglial cells kept under cell culture condi tions lost their capability for cysteinyl-L T biosyn thesis rather rapidly. Therefore, we decided to study the blood-brain cell interaction in vitro using freshly dissociated rat brain cells (Tildon and Roeder, 1988 ) coincubated with physiologically re calcified autologous whole blood.
METHODS

Animal preparation
Male Wistar rats weighing 400-600 g were briefly anes thetized with diethyl ether. The peritoneal cavity was opened and up to 5 ml of blood was collected from the abdominal aorta into 3.8% trisodium citrate (final concen tration, 0.38%). The descending aorta was clamped, and a cannula was introduced into the ascending aorta via the left ventricle. The right ventricle was opened and brain tissue was flushed blood-free with 30 ml of ice-cold phys iological saline. After decapitation, brain tissue was re moved from the skull and immediately transferred into ice-cold saline.
Cell preparation
Dissociated brain cells were prepared basically as de scribed by Tildon and Roeder (1988) . In brief, cerebel lum, brain stem, and meninges were removed. Remaining tissue was weighed, moistened with ice-cold 0. 9% NaCl, and minced on the precooled stage of a tissue chopper into 1-mm3 tissue pieces. The minced tissue was sus pended in 30 ml of ice-cold 0.9% NaCI in a chilled 50-ml conical polypropylene centrifuge tube. This volume of 0. 9% NaCl led to a yield of protein in the final cell sus pension of 4-7 mg/ml as determined by the method of Bradford (1976) using bovine serum albumin as standard. The tissue was triturated until the suspension moved eas ily through the orifice of a lO-ml pipette. After vigorous vortexing for 1 min, the tissue suspension was filtered through nylon cloth (Nitex; pore size, 355 fl.m) and fil-J Cereb Blood Flow Metab, Vol. 16, No. 4, 1996 tered again through a finer sieve (Nitex; pore size, 75 fl.m). The cells were washed twice in 50 ml of Krebs Henseleit solution at 4°C and centrifuged at 355 R for 10 min. The cells were resuspended in 50 ml of Krebs Henseleit solution and preincubated at 37°C for 30 min. After centrifugation the cell pellet was resuspended in -8 ml of Krebs-Henseleit solution and adjusted to a protein concentration of 5 mg/ml; this cell suspension was used for the experiments. As described by Tildon and Roeder (1988) , viability of the cells was >80% as judged by try pan blue dye exclusion.
Recalcification of whole blood or plasma
Plasma was prepared by centrifugation of whole blood at 4°C and 2,500 g for 20 min. Until used, blood and plasma were stored in polypropylene tubes at 4°C. On incubation, whole blood or plasma was recalcified with 0. 3 M CaClz solution, resulting in a final concentration of 1. 1 mM of free Ca 2 + ions as determined by a Ca 2 +sensitive electrode (Orion Research, Cambridge, MA, U.S.A.) (Weide et aI., 1994) .
Experimental protocol
All incubations were performed in polypropylene tubes. Generally, 1 ml of brain cells adjusted to a protein concentration of 5 mg/ml in Krebs-Henseleit solution equilibrated with carbogen (0zlC0 2 , 95/5%) was coincu bated for up to 60 min with either 0.5 ml of Krebs Henseleit solution, autologous plasma, or blood. In ex periments with plasma or blood, the material was physi ologically recalcified as already described.
In experiments with varying amounts of blood, the brain cells (5 mg in terms of protein) were suspended in 0.5 ml of Krebs-Henseleit solution; Krebs-Henseleit so lution was added to give a final incubation volume of 1.5 ml. When aprotinin, o-Phe-Pro-Arg-CH 2 CI (PPACK), or the recombinant hirudin HBW 023 [(Leu 1 , Thr 2 )-63desulphohirudin; Behringwerke AG/Hoechst AG] was used, the relevant compound was dissolved in 0.9% NaCI and added in a volume of 15 fl.1. Controls received the appropriate amounts of 0. 9% NaCI.
Analytical procedure
Prior to radioimmunological determination of cystei nyl-L T, proteins contained in the samples were precipi tated by addition of three volumes of ice-cold acetone. After storage at -20°C for 40 min, proteins were pelleted by centrifugation at 3000 g and 4°C for 20 min. After evaporation of the supernatants, the residues were resus pended in 10 mM of Tris-HCl, pH 7.4, for radioimmuno logical quantitation of cysteinyl-L T. Cysteinyl-L T were calculated in terms of L TC4-like material. All standard curves were run through the same procedure as the sam ples; therefore, the values presented are corrected for potential losses during the extraction procedure. The de tection limit of the radioimmunoassay is 5.9 fmol per tube for L TC4. The antiplasma used recognizes mainly L TC4 but exhibits 78 and 49% relative cross-reaction with LTD4 and LTE4, respectively (Simmet and Tippler, 1990; Sim met et aI., 1990) .
For characterization of cysteinyl-L T by reversephase HPLC, the material was extracted by solid-phase extrac tion using C 1 8-SEP PAK as previously described (Sim met et aI., 1988a (Sim met et aI., , 1988b (Sim met et aI., , 1990 . The residue was redis solved in 30% methanol (vol/vol) and injected onto a C 18-Nucleosil column (250 x 4 mm; particle size, 5 fl.m; Macherey Nagel, Duren, Germany) protected by a pre column using the solvent system methanol:water:acetic acid (65:35:0.1; vol/vol/vol; pH 5. 6) containing ethylene diaminetetraacetic acid dis odium (EDTA), 1 mM. UV ab sorbance was scanned at 280 nm, and all samples con tained PGB2 as an internal standard. Eluted fractions col lected in I-min intervals were evaporated, resuspended, and finally tested in the radioimmunoassay for cysteinyl LT (Simmet et aI., 1988a (Simmet et aI., , 1988b (Simmet et aI., , 1990 .
Statistics
Means ± SD were calculated and statistical analysis was performed by analysis of variance and the Newman Keuls test. Differences were considered significant at p < 0. 05.
RESULTS
Cysteinyl-L T generation in vitro
Dissociated rat brain cells equivalent to 5 mg of protein and incubated in a final volume of 1.5 ml of Krebs-Henseleit solution saturated with carbogen at 37°C for up to 60 min did not release detectable amounts of immunoreactive cysteinyl-LT ( Fig. 1 ).
Incubation of a mixture of 0.5 ml of physiologi cally recalcified rat whole blood with 1 ml of Krebs Henseleit solution led to a time-dependent release of small amounts of cysteinyl-LT; a maximum of 155 ± 74 pg/1.5 ml was reached at 15 min, and the amount decreased slightly to 125 ± 12 pg/1.5 ml at 60 min (n = 4 each; Fig. 1 ).
However, when 0.5 ml of physiologically recalci fied rat whole blood was coincubated with dissoci ated autologous brain cells equivalent to 5 mg of protein in 1 ml of Krebs-Henseleit solution, a time dependent release of large amounts of immunoreac- nyl-L T from 0.5 ml of recalcified whole rat blood coincu bated with 1 ml of Krebs-Henseleit solution (circles) and from rat brain cell suspensions (1 ml) coincubated either with 0.5 ml of Krebs-Henseleit solution (squares), 0.5 ml of recal cified autologous whole blood (diamonds), or 0.5 ml of re calcified autologous plasma (triangles). The values are means ± SO of four independent experiments in each group; d.l., detection limit. tive cysteinyl-LT was observed. Release of cystei nyl-LT reached a plateau phase at 15 min of 762 ± 44 pg/l.5 ml, which did not significantly change at 60 min at 795 ± 150 pg/l.5 ml (n = 4 each; Fig. 1 ). Coincubation of 0.5 ml of physiologically recalci fied rat plasma with 1 ml of dissociated autologous rat brain cells (5 mg of protein) similarly led to a time-dependent release of cysteinyl-L T, although to a diminished extent (Fig. 1) . A plateau phase was reached at 15 min of 399 ± 76 pg/l.5 ml (n = 4), and a slight decrease of immunoreactive material was observed after 60 min of incubation (349 ± 74 pg/1.5 ml; n = 4; Fig. 1 ).
Characterization of immunoreactive cysteinyl-LT by reverse-phase HPLC
Because the anti-cysteinyl-LT antiplasma used cross-reacts with LTC4, LTD4, and LTE4 to a con siderable extent, immunoreactive cysteinyl-LT were further characterized by reverse-phase HPLC. As shown in Fig. 2A , coincubation of recalcified rat whole blood with dissociated autologous brain cells for 15 min led to generation of immunoreactive cys teinyl-LT, which coeluted mainly with the reten tion times of synthetic L TC4 and L TE4. Smaller amounts of immunoreactivity comigrated with the retention time of LTD4.
When dissociated rat brain cells were coincu bated with recalcified autologous plasma for 15 min, the largest portions of immunoreactivity consisted of LTD4 and LT E4, but only a slightly smaller amount of immunoreactive material comigrated with LTC4 ( Fig. 2B ).
Dependence of cysteinyl-L T formation on the relative concentration of blood
Since the data obtained indicated that blood con tains a trigger mechanism activating the 5-lipoxy genase pathway during blood-brain cell contact in brain cells, we tested the effects of various amounts of recalcified autologous blood on cysteinyl-L T generation. As Fig. 3 demonstrates, incubation of dissociated rat brain cells (5 mg in terms of protein) with increasing amounts of recalcified autologous blood for 15 min led to a concentration-dependent increase in cysteinyl-LT release, which released 882 ± 157 pg/l.5 ml (n = 3) when brain cells in a volume of 0.5 ml were coincubated with 1 ml of recalcified blood.
Effects of compounds inhibiting serine proteases on
the release of immunoreactive cysteinyl-L T Because previous studies had shown that plasmin generated in the course of blood coagulation might stimulate the 5-lipoxygenase pathway in human monocytes (Weide et al., 1994) , we tested the po- tential effects of aprotinin, a potent inhibitor of plasmin (Stephens et aI., 1989) . However, this com pound, at amounts from 1 to 1000 KIU/ml, had no effect on cysteinyl-LT formation during blood brain cell contact (data not shown), precluding par ticipation of plasmin or other aprotinin-sensitive proteases in the trigger mechanism involved. Stimulation of the 5-lipoxygenase pathway by clotting plasma clearly implicates a link to the co agulation process. In further experiments, we there fore tested the effects of compounds inhibiting the activity of thrombin. As shown in Fig. 4A , the chlo romethylketone PPACK, as a highly specific throm bin inhibitor, inhibited the cysteinyl-L T release in a concentration-dependent manner when 0.5 ml of re calcified whole blood was coincubated with 1 ml of autologous dissociated rat brain cells (5 mg of pro- Additional experiments with the highly specific thrombin inhibitor recombinant hirudin (HBW 023) revealed similar concentration-dependent inhibi tory effects as seen with PPACK ( Fig. 4B ). Com pared with controls, HBW 023 (0.75 /-LM) reduced cysteinyl-LT release by 47.8 ± 11.9% (n = 7; p < 0.01) when 0.5 ml of recalcified whole blood was coincubated with 1 ml of autologous dissociated brain cells (5 mg of protein) for 15 min. At 3.0 /-LM, HBW 023 cysteinyl-LT release was reduced by 77.9 ± 9.3% (n = 9; p < 0.01; Fig. 4B ).
Both PPACK and HBW 023 at the highest con centrations used, i.e., 10 and 3 /-LM, respectively, had no effect on the cysteinyl-LT formation trig- teinyl-L T formation by dissociated rat brain cells coincu bated with recalcified autOlogous blood at 3rC for 15 min. The columns are means ± SD. The numbers within the col umns indicate the number of experiments; .. , p < 0.01 versus controls without the thrombin inhibitor.
gered by stimulation of dissociated brain cells with the Ca 2+ ionophore A23187 (10 fLM; data not shown).
Effects of human a-thrombin on cysteinyl-LT formation by dissociated rat brain cells
Since the experiments with the thrombin inhibi tors suggested involvement of thrombin in the trig ger mechanism activated during blood-brain cell contact, we investigated the effects of various con centrations of human a-thrombin on cysteinyl-LT release from dissociated rat brain cells (5 mg of pro tein) incubated in 1.5 ml of Krebs-Henseleit solu tion at 37°C for 15 min. Human a-thrombin trig gered a concentration-dependent stimulation of the 5-lipoxygenase pathway in dissociated rat brain cells (Fig. 5) . A maximum cysteinyl-LT release of 912 ± 89 pg/l.5 ml was observed at an a-thrombin concentration of 3 Ulml (n = 5). At 6 Ulml of a-thrombin, cysteinyl-LT release decreased to 719 ± 233 pglml (n = 5; Fig. 5 ).
DISCUSSION
Cerebral vasospasm following SAH due to rup ture of an intracranial aneurysm may trigger severe cerebral ischemia and infarction. Despite intensive research, the pathogenesis of arterial vasospasm and neuronal damage is poorly understood. Sub stantial evidence suggests it to be multifactorial, and numerous compounds in circulating blood have been implicated in the induction of early and late vasospasm following SAH (Findlay et aI., 1991) . Among the potential vasoconstrictors, hemoglobin, endothelin, and the 5-lipoxygenase-derived cystei nyl-LT have gained considerable interest. Elevated levels of cysteinyl-LT in brain tissue and CSF have been described in association with SAH in a variety of species, including humans (Rodriguez y Baena et aI., 1987) . Cysteinyl and LT are vasospastic agents in pe ripheral tissues, but the results regarding their ac tivity on cerebral tissues have not been unequivocal . Nevertheless, the ma jority of studies suggest a vasoconstrictor activity of cysteinyl-L T in cerebral blood vessels .
Since cysteinyl-LT supposedly acts as a media tor of vasospasm following SAH, it is obviously important to gain some insight into the activation mechanism involved in the 5-lipoxygenase stimula tion under those circumstances. To the best of our knowledge, a specific trigger mechanism leading to activation of cysteinyl-LT biosynthesis during blood-brain cell contact has not yet been identified. To investigate the mechanism activating the 5-li poxygenase pathway during SAH, we reduced the complex in vivo models of SAH to a simple blood brain cell contact model in vitro. This approach per mits pharmacological modulation of processes po tentially involved in 5-lipoxygenase activation.
Our results clearly demonstrate that coincubation of physiologically recalcified whole blood with au tologous dissociated rat brain cells triggers a time dependent biosynthesis of cysteinyl-LT. In con trast, incubation for up to 60 min of dissociated rat brain cells alone was not accompanied by any de tectable release of cysteinyl-LT, while incubation of physiologically recalcified whole blood led to a time-dependent generation of only small amounts of cysteinyl-LT. These in vitro findings are in line with previous data showing that cysteinyl-LT lev els in clotted gerbil blood or ex vivo brain tissue were rather low, while intracerebroventricular in jection of freshly clotted blood led to a large in crease in cerebral cysteinyl-LT contents (Kiwak et aI., 1985) . Moreover, in experiments ex vivo with rat brain tissue slices incubated in vitro subsequent to intracisternal injection of autologous blood, in creased biosynthesis of cysteinyl-LT was also re ported (Rodriguez y Baena et aI., 1989; Gaetani et aI., 1990) .
Numerous investigators have used the two hemorrhage model in dogs (Yokota et aI., 1987; Shimizu et aI., 1988; Watanabe et aI., 1988) . In this model, where 5-lipoxygenase activity seems to be induced in basilar blood vessels by the injection of blood, 5-lipoxygenase inhibitors such as AA-861 and 1,2-bis(nicotinamido)propane or a cysteinyl LT antagonist, ONO-1078, were found to have ther apeutic effects on the delayed cerebral vasospasm, providing strong evidence for a pathophysiological role of cysteinyl-LT under these conditions (Yokota et aI., 1987; Shimizu et aI., 1988; Watanabe et aI., 1988; Kobayashi et aI., 1992) .
The data presented here extend the findings from those in vivo models by showing that there exists no absolute requirement for contact of whole blood with brain cells for stimulation of cysteinyl-L T bio synthesis. Instead, physiologically recalcified plasma is apparently sufficient for activation of 5-li poxygenase activity in dissociated brain cells. This finding clearly shows that, first, the dissociated brain cells probably represent a major source of cysteinyl-LT during short-term blood-brain cell contact. A similar conclusion was drawn from ex periments in gerbils subjected to experimental SAH, in which brain cells were suggested to be the major source of cysteinyl-LT (Kiwak et aI., 1985) . Second, the activation mechanism ought to be present in recalcified plasma. Interestingly, in dogs intracisternal injection of plasma was found to elicit early vasospasm only (Nozaki et aI., 1990) . The time course of cerebral cysteinyl-LT levels after SAH in gerbils is also in favor of a role of cysteinyl LT during early vasospasm (Kiwak et aI., 1985) . An early acute cerebral vasospasm after SAH is known to occur in both humans (Taneda et aI., 1990) and rats (Delgado et aI., 1985) . The rapid generation of cysteinyl-LT, as seen in our in vitro experiments, makes these compounds probable mediators during the acute phase of cerebral vasospasm, as has been suggested for the gerbil model (Kiwak et aI., 1985) . However, after experimental SAH, rat brain tissue slices were reported to exhibit enhanced cysteinyl LT formation for up to 2 days after injection (Rod riguez y Baena et aI., 1989; Gaetani et aI., 1990) . Independent from an initial activation of cysteinyl LT biosynthesis, such prolonged generation of cys teinyl-LT could additionally be due to induction of the 5-lipoxygenase enzyme, as reported for the dog model (Watanabe et aI., 1988) .
The fact that recalcified plasma stimulates acti vation of the 5-lipoxygenase pathway led us to as sume that the trigger mechanism might be related to activation of the coagulation cascade during plasma-brain cell contact. We have previously shown that the process of blood coagulation can stimulate monocyte 5-lipoxygenase via plasmin (Weide et aI., 1994) . However, aprotinin, which is known to inhibit plasma even in its membrane bound form (Stephens et aI., 1989) , was unable to affect cysteinyl-LT formation during blood-brain cell contact, indicating that plasmin was not in volved in the trigger mechanism.
By contrast, when we coincubated whole blood and brain cells in the presence of PPACK, a highly J Cereb Blood Flow Metab, Vol. 16, No.4. 1996 selective chloromethylketone substrate that co valently reacts with the catalytic center of a-throm bin (Kettner and Shaw, 1979; Bode et aI., 1989) , a significant and concentration-dependent inhibition of cysteinyl-LT formation was observed, suggest ing that thrombin might be involved in the activa tion of the 5-lipoxygenase pathway. Moreover, co incubation of whole blood and brain cells in the presence of recombinant hirudin, a highly specific polypeptide inhibitor of thrombin originally derived from the European medicinal leech Hirudo medici nalis (Rydel et aI., 1990) , also yielded a concentra tion-dependent and significant inhibition of cystei nyl-LT formation during blood-brain cell contact. Hirudin is known to form stable complexes with thrombin by binding to the catalytic and anion bind ing sites of the thrombin molecule (Rydel et aI., 1990) . Similar to findings in previous experiments with human blood cells (Simmet and Weide, 1991) , we did not observe any effects of the thrombin in hibitors on the ionophore A23187-induced cystei nyl-L formation, thereby excluding a nonspecific interaction of those compounds with 5-lipoxygen ase activity.
In our last approach to demonstrating the signif icance of thrombin as a stimulus for the 5-lipoxy genase pathway during blood-brain cell contact, we used human a-thrombin to stimulate the dissociated rat brain cells. Human a-thrombin exhibits a high degree of sequence homology with rat a-thrombin (Banfield and MacGillivray, 1992) and is known to interact with thrombin receptors in rat tissues (An tonaccio et aI., 1993) . When dissociated rat brain cells were incubated in Krebs-Henseleit solution in the presence of human a-thrombin, a concentra tion-dependent stimulation of cysteinyl-LT biosyn thesis was observed, which reached a maximum at � 3 U/mI. Indeed, the amounts of cysteinyl-LT re leased by this concentration of a-thrombin were comparable with those detected after coincubation of recalcified whole blood with dissociated rat brain cells. Beyond this optimal concentration of human a-thrombin, release of cysteinyl-LT tended to de crease again. The reason for the apparently reduced efficacy of thrombin at the highest concentration used is unknown. However, such a concentration response curve is not uncommon for thrombin, as it has also been observed in a mouse macrophage cell line, in which thrombin exerts mitogenic effects (Bar-Shavit et aI., 1986) , and in human monocytes, in which thrombin was found to trigger a chemotac tic response (Bar-Shavit et aI., 1983) .
It is well-known that cerebral tissues are a rich source of tissue factor, the primary cellular initiator of blood coagulation (Drake et aI., 1989; Nemerson, 1992) . In the CNS of the baboon, tissue factor an tigen and related procoagulant activity are confined primarily to gray matter parenchyma and to the noncapillary microvasculature (del Zoppo et aI., 1992) . In addition, mouse, rat, and human astrocyte cell lines constitutively express tissue factor mRNA as well as functional protein (EddIes tone et aI., 1993) . Therefore, it is reasonable to assume that under our in vitro conditions, tissue factor gener ated by dissociated brain cells might trigger activa tion of the coagulation cascade. However, the pre cise role of tissue factor in our model will have to be elaborated in further experiments, perhaps with monoclonal antitissue factor antibodies.
Thrombin receptor mRNA is broadly distributed across the neuroaxis (Weinstein et aI., 1995) . Al though white matter was found to be negative, pat terns of hybridization included neuronal, glial, and ependymal cells. Since prothrombin mRNA was found in codistribution with thrombin receptor mRNA in rat brain, it has been suggested that the thrombin-thrombin receptor cell signaling system might have multiple physiologic, and possibly pathophysiologic, functions in the CNS (Weinstein et aI., 1995) . From our data, we cannot conclude which cell type is activated by thrombin during blood-brain cell contact. We and others have shown that rat astroglia might serve as a source of cerebral cysteinyl-LT formation (Simmet and Pes kar, 1990) , and astroglial cells are known to respond to thrombin. Indeed, thrombin can induce expres sion of c-fos and c-jun mRNA in astroglial cells (Trejo et aI., 1992) and the synthesis and secretion of nerve growth factor (Neveu et aI., 1993) and en dothelin-1 (Ehrenreich et aI., 1993) , which has also been suggested to play a pathophysiological role during delayed vasospasm (Findlay et aI., 1991) .
The fact that thrombin is the stimulus involved in activation of the cerebral 5-lipoxygenase pathway during blood-brain cell contact may at least par tially explain why dissociated brain cells incubated in the presence of recalcified plasma generate less cysteinyl-LT than do brain cells coincubated with recalcified whole blood. Platelets, which were not present in the plasma preparation but were in the whole blood samples, of course are important for activation of the coagulation cascade. They provide an appropriate "surface membrane" for the effi cient assembly of the prothrombinase complexes and thereby enhance the amount of thrombin gen erated (Tracy et al., 1985) . While this might lead to further enhancement of the thrombin-stimulated 5-lipoxygenase pathway, platelets could also con tribute to an enhanced cysteinyl-L T biosynthesis by converting the instable intermediate LT A4 re-leased by brain cells to LTC4, as has been observed in coincubation of monocytes with platelets (Weide et aI., 1994) . By the same mechanism, polymorpho nuclear leukocytes could contribute to cysteinyl LT formation. Only recently, it has been reported that cysteinyl-L T biosynthesis by neutrophils seems to require uptake of exogenous LT A4 (Pal mentier et aI., 1995) .
In conclusion, our data demonstrate that throm bin generated during blood-brain cell contact is the stimulus triggering activation of the 5-lipoxygenase pathway of arachidonic acid metabolism in brain cells. Thrombin-mediated activation of brain cells may be important for our understanding of the pathophysiology of SA H since thrombin stimulates cerebral release of cysteinyl-LT and endothelin (Ehrenreich et aI., 1993) , compounds purportedly involved in the development of vasospasm. To our knowledge, this is the first report of thrombin mediated stimulation of the 5-lipoxygenase pathway of arachidonic acid metabolism. The significance of the thrombin-mediated 5-lipoxygenase stimulation will be further investigated in experiments in vivo by the combined intracerebroventricular applica tion of autologous blood and thrombin inhibitors such as hirudin.
